Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial

Authors

Institutions

Publication Details

Journal
The Lancet
Published
2025-10-01
DOI
https://doi.org/10.1016/s0140-6736(25)01432-1
Citations
6
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
8.83
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial

Moez Dungarwalla, Karin Papworth, Rebecca Auer, Andy C. Rawstron et al.
6 citations
The Lancet
Lymphoma Diagnosis and Treatment
8.83
article

Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial

Moez Dungarwalla, Karin Papworth, Rebecca Auer, Andy C. Rawstron, Nimish Shah, Renata J. Walewska, Nevzeta Kuric, Oonagh Sheehy, Nicholas Morley, Marjukka Pollari, Deborah Turner, Ingemar Lagerlöf, Andrew Hodson, Karin Fahl Wader, Annika Pasanen, Kim Linton, Adam Forbes, Dominic Culligan, M. Wilson, Pam McKay, David Lewis, Lexy Sorrell, M. Ruparelia, Catherine Burton, Mats Jerkeman, Juanah Addada, Somaiah Aroori, Catharina Lewerin, Gavin Campbell, Mark Bishton, Jon Riise, Sunil Iyengar, Clare J. Rowntree, Pär Josefsson, Igor Singer, J. Sanders, Unmesh Mohite, Santosh Narat, Arvind Arumainathan, Kristina Sonnevi, Piers Patten, F. J. Cutler, Paul Kerr, Jonathan Cullis, Rory McCulloch, Maadh Aldouri, Ruth Pettengell, Toby A. Eyre, Christian Bjørn Poulsen, Chris McNamara, Fiona Miall, Paul Micallef-Eynaud, Cathy Burton, Ingrid Cecilia Glimelius, A. Paige Whittle, Lena Brandefors, Shankara Paneesha, Victoria Allgar, Wendy Osborne, Andrew John Davies, Moya Young, Beth D. Harrison, Nicola Crosbie, Russell Patmore, Richard Lush, Ruth de Tute, Robert Boulton-Jones, Sudarshan Gurung, Peter Forsyth, Surita Dalal, Michelle Furtado, Brian Wainman, Mark Warner, D. Wright, Vikram Singh, David Lewis, Jacob Haaber Christensen, C Scully, Mohsen Norouzi, Yasmin Hasan, Hans Bentzen, Helle Toldbod, Angus Broom, Marian Macheta, James Milnthorpe
article en
6 citations

Abstract

No abstract available for this paper.
The LancetVol. 406(10514)
AstraZeneca (United Kingdom) (GB), Uppsala University (SE), Oslo University Hospital (NO), Karolinska University Hospital (SE), University of Nottingham (GB), University of Exeter (GB), Leeds Teaching Hospitals NHS Trust (GB), Helsinki University Hospital (FI), Churchill Hospital (GB), Odense University Hospital (DK), Aarhus University Hospital (DK), Zealand University Hospital (DK), Sheffield Teaching Hospitals NHS Foundation Trust (GB), St Olav's University Hospital (NO), Skåne University Hospital (SE), Linköping University Hospital (SE), University Hospitals Plymouth NHS Trust (GB), University of Southampton (GB), University College London (GB), University of Plymouth (GB)
Openalex Percentile: Top 2%
Lymphoma Diagnosis and Treatment
8.83
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.